Teijin Limited

Tokyo Stock Exchange 3401.T

Teijin Limited Return on Assets (ROA) for the year ending March 31, 2024: 0.85%

Teijin Limited Return on Assets (ROA) is 0.85% for the year ending March 31, 2024, a 159.49% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

Teijin Limited Return on Assets (ROA) for the year ending March 31, 2023 was -1.42%, a -174.27% change year over year.
Teijin Limited Return on Assets (ROA) for the year ending March 31, 2022 was 1.92%, a 398.34% change year over year.
Teijin Limited Return on Assets (ROA) for the year ending March 31, 2021 was -0.64%, a -125.56% change year over year.
Teijin Limited Return on Assets (ROA) for the year ending March 31, 2020 was 2.51%, a -43.04% change year over year.

Key data

Date	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio

Tokyo Stock Exchange: 3401.T

Teijin Limited

CEO	Mr. Akimoto Uchikawa
IPO Date	Jan. 4, 2000
Location	Japan
Headquarters	Kasumigaseki Common Gate West Tower
Employees	21,834
Sector	Materials
Industries Composite Materials Chemicals & Advanced Materials Paper & Forest Products Pharmaceuticals

Description

Teijin Limited engages in the fibers, films and sheets, composites, healthcare, and IT businesses worldwide. It offers aramid fibers and polyethylene materials; carbon fibers, composite materials, and oxidized PAN fibers; polycarbonate sheets and films; high-density polyethylene porous films and materials; and microporous films. The company also provides PC resins, polyphenylene sulfide resins, molded parts, and additives; lightweight glass and carbon fiber reinforced composites for automotive applications; and polytrimethylene telephthalate products, artificial leather materials, polyester nanofibers, and recycled polyester fibers. In addition, it offers pharmaceuticals for bone and joint, respiratory, cardiovascular and metabolic, and other diseases; home oxygen therapy, non-invasive positive pressure ventilation, rehabilitation, and sleep disordered breathing related devices, as well as sonic accelerated fracture healing system and community-based integrated care system; and orthopedic implantable devices, and functional food ingredients. Further, the company provides Recopic, a radio-frequency identification technology for inventory management. Additionally, it develops and implements engineering solutions for various issues, such as environmental pollution, energy supply stability, and aging-related workforce population decline. Teijin Limited was incorporated in 1918 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years